Axogen, Inc. 8-K

What Happened

• Axogen, Inc. (AXGN) filed a Form 8‑K on April 28, 2026 to announce its first quarter 2026 financial results via a press release. The company also posted updated financial-results and corporate presentations to its investor website and said it may use these materials when speaking with analysts, investors and others. The filing was signed by Marc Began, Executive VP, General Counsel and Chief Compliance Officer.

Key Details

• Date of disclosure: April 28, 2026 (Form 8‑K filed and materials posted).
• Press release furnished as Exhibit 99.1 and Q1 results presentation furnished as Exhibit 99.2; corporate presentation furnished as Exhibit 99.3.
• Presentations available at Axogen’s investor site: https://ir.axogeninc.com/news-events.
• Disclosure made under Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD Disclosure).

Why It Matters

• This 8‑K publicly announces Axogen’s latest quarterly performance and provides investor-facing slides that analysts and shareholders can use to evaluate recent results and company guidance.
• Posting of the press release and presentations under Regulation FD means the company has broadly disclosed the information to the market, which can influence analyst coverage and trading reactions once the results are reviewed.
• Investors should review the furnished press release and presentations for the specific revenue, earnings and operational details not reproduced in the 8‑K summary.